← Back to companies
Centivax
0 open2 filled
South San Francisco, California, United StatesFounded 202032+ employeesSeed raisedSeedPrivate
Last round: series unknown · $37M · Mar 2026(5 rounds total)
Founded by Jacob Glanville, Sawsan Youssef“Smash the mutants”
Backed by(20 investors)
Structure FundFuture VenturesGlobal Health Investment CorporationHenry M. Jackson FoundationNFXKendall Capital PartnersJohn CollisonSigmas GroupPatrick CollisonMeiji Seika PharmaCoalition for Epidemic Preparedness InnovationsMilitary Infectious Diseases Research ProgramU.S. Department of DefenseUnited States Navy Bureau of Medicine and SurgeryBill & Melinda Gates Foundation
Centivax develops broad-spectrum vaccines and therapeutic antibodies targeting infectious diseases and venomous threats. The company advances a universal influenza vaccine, antibody-based antivenoms effective across multiple snake species, and broad-spectrum anti‑infective programs against drug-resistant bacteria.
Open Positions at Centivax (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Centivax?
